<DOC>
	<DOCNO>NCT02993575</DOCNO>
	<brief_summary>The pharmacokinetics flucloxacillin expect different ICU patient compare non-ICU patient . The investigator determine total free flucloxacillin concentration 30 ICU patient , get continuous ( n=10 ) intermittent infusion ( n=20 ) flucloxacillin standard care . Full pharmacokinetic curve take individual patient intermittent dose regimen limit sample take individual patient continuous dose regimen day 2 4 .</brief_summary>
	<brief_title>Pharmacokinetics Flucloxacillin Given Continuous Intermittent Infusion ICU Patients</brief_title>
	<detailed_description>The pharmacokinetics flucloxacillin expect different ICU patient compare non-ICU patient . There substantial risk present standard dose regimen antibiotic lead suboptimal outcome patient ICU . To prevent risk inadequate dose critically ill patient , important optimize dose regimen ICU patient . With study investigator define pharmacokinetics flucloxacillin ICU patient search variable influence pharmacokinetics . By use population model investigator simulate different dosing regimen , intermittent continuous , compare probability target attainment continuous intermittent infusion . To able include 30 patient within study duration , multi-centre approach necessary . Patients receive standard care , state product characteristic accord local protocol . Minimally invasive blood sample pharmacokinetic analysis retrieve central venous catheter arterial line . Full pharmacokinetic curve take individual patient intermittent dose regimen limit sample take individual patient continuous dose regimen day 2 4 .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Floxacillin</mesh_term>
	<criteria>1 . Patient admit ICU 2 . Subject least 18 year old day first dose 3 . Is managed central venous catheter arterial line 4 . Patient treat flucloxacillin 1 . Has previously participate trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Flucloxacillin</keyword>
	<keyword>Continuous infusion</keyword>
	<keyword>Intensive Care Unit</keyword>
</DOC>